Ayurvedic management of Diabetic Nephropathy (stage 1 and 2)

Management of Diabetic Nephropathy (Stage 1 and 2) by using Ayurveda Medications Ã¢â?¬â?? An Open Labelled Single Arm Study

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/09/045629

Enrollment

Registered

2022-09-19

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E132- Other specified diabetes mellituswith kidney complications Health Condition 2: E112- Type 2 diabetes mellitus with kidney complications Health Condition 3: E112- Type 2 diabetes mellitus with kidney complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Diabetic patients having controlled blood glucose level upto FBS:130mg/dl PPBS:180mg/dl. (American Diabetes Association) c) Hypertensive patients BP d) Urinary albumin between 30-300mg in 24 Hr. urine sample e) G.F.R. between 60-120ml/min/1.73m2

Exclusion criteria

Exclusion criteria: Uncontrolled diabetic patients if blood glucose level more than- FBS: 130 mg/dl PPBS:180 mg/dl b) Uncontrolled Hypertensive patients BP Ã¢â?°Â¥140/90 mm of Hg. c) Microalbuminuria originating due to other diseases d) Patients with other severe complications of Diabetes Mellitus. e) Serum creatinine more than 2.5 mg. f) Albumin >300mg/day. g) G.F.R. h) Any other serious systemic illness.

Design outcomes

Primary

Measure	Time frame
To evaluate efficacy of selective Ayurvedic formulations on progression of diabetic kidney disease in 30 days disease. Timepoint: 30 days	—

Secondary

Measure	Time frame
To evaluate the Glomerular filtration Rate (eGFR) and Renal functionsTimepoint: 30 days	—

Countries

India

Contacts

Public ContactDr Vyasadeva Mahanta

ALL INDIA INSTITUTE OF AYURVEDA

drvyasayu@gmail.com8368104072

Outcome results